Clinical evidence
Heli-FX™ EndoAnchor™ system
Review the results of clinical studies and trials related to the effectiveness of the Heli-FX™ EndoAnchor™ system.
Wide neck cohort (n = 72)
(N = 6,602 f/u ranged from 2.7 years [mean] to 3.9 years)
ESAR reinforces and protects the proximal seal, leading to better outcomes in wide necks. View data on wide necks from literature compared to the three-year wide neck results from the ANCHOR Registry.
(Wide necks ≥ 28 mm and ≤ 32 mm mean neck diameter 29.5 mm)
Hear from Professor Michel Reijnen on the importance of the ANCHOR three-year wide neck data. (03:33)
Dr. William Jordan Jr. discusses the ANCHOR Registry and how it captures real-world usage and long-term outcomes of EndoAnchor™ implant fixation in EVAR. (01:10)
Primary AAA arm (n = 771)4
Learn about the ANCHOR Registry design methods, results, and proven durability of ESAR with the Heli-FX™ EndoAnchor™ system in challenging AAA patients. (02:21)
| ANCHOR primary AAA arm | N = 771 |
|---|---|
| Female | 21.3% |
| Average age | 73.5 years |
| Hostile necks | 88.7% (572/645) |
| ASA Class III/IV | 87.8% (674/768) |
| Urgent or emergent | 17.9% (119/664) |
| ANCHOR primary AAA arm | N = 771 |
|---|---|
| Technical success9 | 98.8% (738/747) |
| Average time to place EndoAnchor™ implants | 19.6 min |
| Average number of EndoAnchor™ implants | 6.0 |
| Average total procedural time9 | 143.7 min |
| Average total fluoro time | 35.1 min |
| ANCHOR primary AAA arm (N = 771) | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Type Ia endoleak | 2.5% (14/568) |
1.7% (6/346) |
2.9% (7/238) |
3.2% (5/154) |
4.8% (4/84) |
| Migration | 0.0% (0/368) |
0.0% (0/180) |
0.0% (0/114) |
0.0% (0/72) |
0.0% (0/37) |
Strong five-year sac regression in hostile necks
ANCHOR five-year results demonstrate durable, reinforced proximal seal
Revision AAA arm (n = 261)11
| ANCHOR revision AAA arm | N = 261 |
|---|---|
| Female | 15.3% |
| Average age | 77.8 years |
| Hostile necks | 88.7% (188/212) |
| ASA Class III/IV | 89.2% |
| Urgent or emergent | 23.8% (58/244) |
| ANCHOR revision AAA arm | N = 261 |
|---|---|
| Technical success | 95% |
| Average time to place EndoAnchor™ implants | 25.2 min |
| Average number of EndoAnchor™ implants | 7.4 |
| Average total procedural time | 145.5 min |
| Average total fluoro time | 32.5 min |
(For 4.6 years, see reference 12.)
| ANCHOR revision AAA arm (N = 261) | Year 5 |
|---|---|
| Type Ia endoleak9 | 3.7% (1/27) |
| Sac regressing or stable11 | 65.4% (17/26) |
| Sac regressing11 | 38.5% (10/26) |
| Migration9 | 0.0% (0/16) |
Five-year revision results over nine years post-index EVAR
Even in failed EVARs, ESAR delivers durability
Short neck cohort (n = 70)13
| ANCHOR short neck cohort | N = 70 |
|---|---|
| Female | 27% |
| Average age | 71 years |
| Hostile necks | 100% |
| ASA Class III/IV | 93% |
| Urgent or emergent | 31% |
| ANCHOR short neck cohort | N = 70 |
|---|---|
| Overall procedural success | 97.1% |
| Successful and accurate deployment of EndoAnchor implants14 | 92.9% |
| Average time to place EndoAnchor implants | 17.1 min |
| Average number of EndoAnchor implants | 5.5 |
| Average total procedural time | 148 min |
| Average total fluoro time | 35.5 min |
| ANCHOR short neck cohort (N = 70) | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Type Ia endoleak | 2.0% (1/51) |
2.7% (1/37) |
6.5% (2/31) |
| Sac regressing or stable | 100% (53/53) |
97.3% (36/37) |
93.7% (30/32) |
| Sac regressing | 35.8% (19/53) |
54.1% (20/37) |
46.9% (15/32) |
| Migration | 0 migrations at any time point |
||
Durable results, minimal reinterventions
Short neck cohort three-year results demonstrate strong outcomes and minimal reinterventions in hostile neck patients
TM* Third-party brands are trademarks of their respective owners.
† Wide neck definition varied from ≥ 25 mm to ≥ 31 mm.
‡ Denominator is the number of subjects with maximum aneurysm diameter reported at both the 1-month post implantation measurement and three-year follow-up time points.